Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium

Clive Wasserfall; Anne Marie Dyer; Cate Speake; Dana K. Andersen; Kendall Thomas Baab; Melena D. Bellin; James R. Broach; Martha Campbell-Thompson; Vernon M. Chinchilli; Peter J. Lee; Walter G. Park; Richard E. Pratley; Jami L. Saloman; Emily K. Sims; Gong Tang; Dhiraj Yadav; Cemal Yazici; Darwin L. Conwell

doi:10.1097/mpa.0000000000002077

Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium

Clive Wasserfall, Anne Marie Dyer, Cate Speake, Dana K. Andersen, Kendall Thomas Baab, Melena D. Bellin, James R. Broach, Martha Campbell-Thompson, Vernon M. Chinchilli, Peter J. Lee, Walter G. Park, Richard E. Pratley, Jami L. Saloman, Emily K. Sims, Gong Tang, Dhiraj Yadav, Cemal Yazici, Darwin L. Conwell

Pediatric Endocrinology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

ABSTRACT: Differences in methods for biospecimen collection, processing, and storage can yield considerable variability and error. Therefore, best practices for standard operating procedures are critical for successful discovery, development, and validation of disease biomarkers. Here, we describe standard operating procedures developed for biospecimen collection during the DREAM (Diabetes RElated to Acute pancreatitis and its Mechanisms) Study within the Type 1 Diabetes in Acute Pancreatitis Consortium. Notably, these protocols were developed using an integrative process based on prior consortium experience and with input from working groups with expertise in immunology, pancreatitis, and diabetes. Publication and adoption consistent biospecimen protocols will inform future studies and allow for better comparisons across different metabolic research efforts.

Original language	English (US)
Pages (from-to)	593-597
Number of pages	5
Journal	Pancreas
Volume	51
Issue number	6
DOIs	https://doi.org/10.1097/mpa.0000000000002077
State	Published - Jul 1 2022

Bibliographical note

Funding Information:
D.K.A. is part of advisory board for National Pancreas Foundation and American Pancreatic, Association Foundation and receives royalties from McGraw-Hill. M.D.B receives research support from Viacyte and Dexcom and is part of advisory board for Insulet. P.J.L. is part of advisory board for AbbVie. R.E.P. has consulting activities with Bayer AG, Corcept Therapeutics Incorporated, Dexcom, Gasherbrum Bio, Inc, Hanmi Pharmaceutical Co, Hengrui (USA) Ltd, Merck, Novo Nordisk, Pfizer, Rivus, Pharmaceuticals, Inc, Sanofi, Scohia Pharma, Inc, and Sun Pharmaceutical Industries; receives research support from Hanmi Pharmaceutical Co, Janssen, Metavention, Novo Nordisk, Poxel, SA, and Sanofi; and receives speaking fees from Novo Nordisk. E.K.S. receives speaking fees from MedScape. C.S. is part of advisory board for Vertex Pharmaceuticals. The other authors declare no conflict of interest.

Funding Information:
The study was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC) under award numbers: U01 DK127367 (Minnesota), U01 DK127377 (Pittsburgh), U01 DK127378 (Illinois at Chicago), U01 DK127382 (Indiana), U01 DK127384 (DCC, Penn State), U01 DK127388 (Ohio State), U01 DK127392 (University of Florida–Advent Health), U01 DK127395 (Stanford), U01 DK127400 (Johns Hopkins), U01 DK127403 (Cedars-Sinai), and U01 DK 127404 (Benaroya-Seattle).

Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.

Keywords

AP - acute pancreatitis
CPDPC - Chronic Pancreatitis Diabetes Pancreas Cancer Consortium
DCC - data coordinating center
DKCR - NIDDK Central Repository
DREAM - Diabetes RElated to Acute pancreatitis and its Mechanisms
LN - liquid nitrogen
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases
PBMC - peripheral blood mononuclear cells
SOP - standard operating procedures
ST - sample tracking module
T1DAPC - Type 1 Diabetes in Acute Pancreatitis Consortium
biorepository
biosamples
immunology
laboratory protocol
pancreas
type 1 diabetes
Acute Disease
Humans
Diabetes Mellitus, Type 1/complications
Specimen Handling/methods
Biomarkers
Pancreatitis/diagnosis

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1097/mpa.0000000000002077

Find It

Find It at U of M Libraries

Cite this

Wasserfall, C., Dyer, A. M., Speake, C., Andersen, D. K., Baab, K. T., Bellin, M. D., Broach, J. R., Campbell-Thompson, M., Chinchilli, V. M., Lee, P. J., Park, W. G., Pratley, R. E., Saloman, J. L., Sims, E. K., Tang, G., Yadav, D., Yazici, C., & Conwell, D. L. (2022). Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium. Pancreas, 51(6), 593-597. https://doi.org/10.1097/mpa.0000000000002077

Wasserfall, C, Dyer, AM, Speake, C, Andersen, DK, Baab, KT, Bellin, MD, Broach, JR, Campbell-Thompson, M, Chinchilli, VM, Lee, PJ, Park, WG, Pratley, RE, Saloman, JL, Sims, EK, Tang, G, Yadav, D, Yazici, C & Conwell, DL 2022, 'Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium', Pancreas, vol. 51, no. 6, pp. 593-597. https://doi.org/10.1097/mpa.0000000000002077

@article{e8f3ca73fdff4735ace653b223427486,

title = "Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium",

abstract = "ABSTRACT: Differences in methods for biospecimen collection, processing, and storage can yield considerable variability and error. Therefore, best practices for standard operating procedures are critical for successful discovery, development, and validation of disease biomarkers. Here, we describe standard operating procedures developed for biospecimen collection during the DREAM (Diabetes RElated to Acute pancreatitis and its Mechanisms) Study within the Type 1 Diabetes in Acute Pancreatitis Consortium. Notably, these protocols were developed using an integrative process based on prior consortium experience and with input from working groups with expertise in immunology, pancreatitis, and diabetes. Publication and adoption consistent biospecimen protocols will inform future studies and allow for better comparisons across different metabolic research efforts.",

keywords = "AP - acute pancreatitis, CPDPC - Chronic Pancreatitis Diabetes Pancreas Cancer Consortium, DCC - data coordinating center, DKCR - NIDDK Central Repository, DREAM - Diabetes RElated to Acute pancreatitis and its Mechanisms, LN - liquid nitrogen, NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, PBMC - peripheral blood mononuclear cells, SOP - standard operating procedures, ST - sample tracking module, T1DAPC - Type 1 Diabetes in Acute Pancreatitis Consortium, biorepository, biosamples, immunology, laboratory protocol, pancreas, type 1 diabetes, Acute Disease, Humans, Diabetes Mellitus, Type 1/complications, Specimen Handling/methods, Biomarkers, Pancreatitis/diagnosis",

author = "Clive Wasserfall and Dyer, {Anne Marie} and Cate Speake and Andersen, {Dana K.} and Baab, {Kendall Thomas} and Bellin, {Melena D.} and Broach, {James R.} and Martha Campbell-Thompson and Chinchilli, {Vernon M.} and Lee, {Peter J.} and Park, {Walter G.} and Pratley, {Richard E.} and Saloman, {Jami L.} and Sims, {Emily K.} and Gong Tang and Dhiraj Yadav and Cemal Yazici and Conwell, {Darwin L.}",

note = "Funding Information: D.K.A. is part of advisory board for National Pancreas Foundation and American Pancreatic, Association Foundation and receives royalties from McGraw-Hill. M.D.B receives research support from Viacyte and Dexcom and is part of advisory board for Insulet. P.J.L. is part of advisory board for AbbVie. R.E.P. has consulting activities with Bayer AG, Corcept Therapeutics Incorporated, Dexcom, Gasherbrum Bio, Inc, Hanmi Pharmaceutical Co, Hengrui (USA) Ltd, Merck, Novo Nordisk, Pfizer, Rivus, Pharmaceuticals, Inc, Sanofi, Scohia Pharma, Inc, and Sun Pharmaceutical Industries; receives research support from Hanmi Pharmaceutical Co, Janssen, Metavention, Novo Nordisk, Poxel, SA, and Sanofi; and receives speaking fees from Novo Nordisk. E.K.S. receives speaking fees from MedScape. C.S. is part of advisory board for Vertex Pharmaceuticals. The other authors declare no conflict of interest. Funding Information: The study was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC) under award numbers: U01 DK127367 (Minnesota), U01 DK127377 (Pittsburgh), U01 DK127378 (Illinois at Chicago), U01 DK127382 (Indiana), U01 DK127384 (DCC, Penn State), U01 DK127388 (Ohio State), U01 DK127392 (University of Florida–Advent Health), U01 DK127395 (Stanford), U01 DK127400 (Johns Hopkins), U01 DK127403 (Cedars-Sinai), and U01 DK 127404 (Benaroya-Seattle). Publisher Copyright: {\textcopyright} Wolters Kluwer Health, Inc. All rights reserved.",

year = "2022",

month = jul,

day = "1",

doi = "10.1097/mpa.0000000000002077",

language = "English (US)",

volume = "51",

pages = "593--597",

journal = "Pancreas",

issn = "0885-3177",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Standard Operating Procedures for Biospecimen Collection, Processing, and Storage

T2 - From the Type 1 Diabetes in Acute Pancreatitis Consortium

AU - Wasserfall, Clive

AU - Dyer, Anne Marie

AU - Speake, Cate

AU - Andersen, Dana K.

AU - Baab, Kendall Thomas

AU - Bellin, Melena D.

AU - Broach, James R.

AU - Campbell-Thompson, Martha

AU - Chinchilli, Vernon M.

AU - Lee, Peter J.

AU - Park, Walter G.

AU - Pratley, Richard E.

AU - Saloman, Jami L.

AU - Sims, Emily K.

AU - Tang, Gong

AU - Yadav, Dhiraj

AU - Yazici, Cemal

AU - Conwell, Darwin L.

N1 - Funding Information: D.K.A. is part of advisory board for National Pancreas Foundation and American Pancreatic, Association Foundation and receives royalties from McGraw-Hill. M.D.B receives research support from Viacyte and Dexcom and is part of advisory board for Insulet. P.J.L. is part of advisory board for AbbVie. R.E.P. has consulting activities with Bayer AG, Corcept Therapeutics Incorporated, Dexcom, Gasherbrum Bio, Inc, Hanmi Pharmaceutical Co, Hengrui (USA) Ltd, Merck, Novo Nordisk, Pfizer, Rivus, Pharmaceuticals, Inc, Sanofi, Scohia Pharma, Inc, and Sun Pharmaceutical Industries; receives research support from Hanmi Pharmaceutical Co, Janssen, Metavention, Novo Nordisk, Poxel, SA, and Sanofi; and receives speaking fees from Novo Nordisk. E.K.S. receives speaking fees from MedScape. C.S. is part of advisory board for Vertex Pharmaceuticals. The other authors declare no conflict of interest. Funding Information: The study was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC) under award numbers: U01 DK127367 (Minnesota), U01 DK127377 (Pittsburgh), U01 DK127378 (Illinois at Chicago), U01 DK127382 (Indiana), U01 DK127384 (DCC, Penn State), U01 DK127388 (Ohio State), U01 DK127392 (University of Florida–Advent Health), U01 DK127395 (Stanford), U01 DK127400 (Johns Hopkins), U01 DK127403 (Cedars-Sinai), and U01 DK 127404 (Benaroya-Seattle). Publisher Copyright: © Wolters Kluwer Health, Inc. All rights reserved.

PY - 2022/7/1

Y1 - 2022/7/1

N2 - ABSTRACT: Differences in methods for biospecimen collection, processing, and storage can yield considerable variability and error. Therefore, best practices for standard operating procedures are critical for successful discovery, development, and validation of disease biomarkers. Here, we describe standard operating procedures developed for biospecimen collection during the DREAM (Diabetes RElated to Acute pancreatitis and its Mechanisms) Study within the Type 1 Diabetes in Acute Pancreatitis Consortium. Notably, these protocols were developed using an integrative process based on prior consortium experience and with input from working groups with expertise in immunology, pancreatitis, and diabetes. Publication and adoption consistent biospecimen protocols will inform future studies and allow for better comparisons across different metabolic research efforts.

AB - ABSTRACT: Differences in methods for biospecimen collection, processing, and storage can yield considerable variability and error. Therefore, best practices for standard operating procedures are critical for successful discovery, development, and validation of disease biomarkers. Here, we describe standard operating procedures developed for biospecimen collection during the DREAM (Diabetes RElated to Acute pancreatitis and its Mechanisms) Study within the Type 1 Diabetes in Acute Pancreatitis Consortium. Notably, these protocols were developed using an integrative process based on prior consortium experience and with input from working groups with expertise in immunology, pancreatitis, and diabetes. Publication and adoption consistent biospecimen protocols will inform future studies and allow for better comparisons across different metabolic research efforts.

KW - AP - acute pancreatitis

KW - CPDPC - Chronic Pancreatitis Diabetes Pancreas Cancer Consortium

KW - DCC - data coordinating center

KW - DKCR - NIDDK Central Repository

KW - DREAM - Diabetes RElated to Acute pancreatitis and its Mechanisms

KW - LN - liquid nitrogen

KW - NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases

KW - PBMC - peripheral blood mononuclear cells

KW - SOP - standard operating procedures

KW - ST - sample tracking module

KW - T1DAPC - Type 1 Diabetes in Acute Pancreatitis Consortium

KW - biorepository

KW - biosamples

KW - immunology

KW - laboratory protocol

KW - pancreas

KW - type 1 diabetes

KW - Acute Disease

KW - Humans

KW - Diabetes Mellitus, Type 1/complications

KW - Specimen Handling/methods

KW - Biomarkers

KW - Pancreatitis/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85139570575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139570575&partnerID=8YFLogxK

U2 - 10.1097/mpa.0000000000002077

DO - 10.1097/mpa.0000000000002077

M3 - Article

C2 - 36206464

AN - SCOPUS:85139570575

SN - 0885-3177

VL - 51

SP - 593

EP - 597

JO - Pancreas

JF - Pancreas

IS - 6

ER -

Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this